Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper

Industry Insight by 2FIRSTS
Apr.15.2024
Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
JAMA retracts e-cigarette quitting study for major coding errors and doubts on accuracy, causing widespread concern and controversy.

Recently, the Journal of the American Medical Association (JAMA) retracted an article published two months ago about vaping e-cigarettes due to researchers notifying the editors of "significant coding errors" and other issues in the study.

Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
Withdrawal page | Image source: American Medical Association Journal

 

This paper titled "Effectiveness of e-cigarettes compared with varenicline and nicotine gum for smoking cessation: a randomized clinical trial" was originally published in the January 29th issue of JAMA Internal Medicine, led by Dr. Liu Zhaobo from the Smoking Control and Respiratory Disease Prevention Department at Beijing Friendship Hospital. The researchers in this study found that in terms of helping people quit smoking, using e-cigarettes is not inferior to prescription medications and is more effective than nicotine gum. The paper has garnered widespread attention in the medical community, non-professional media, and social media.

 

Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
Withdrawal notice | Image source: Journal of the American Medical Association

 

However, the article was later retracted.

 

The retraction notice for this paper was issued on March 29th as follows:

 

We have identified significant coding errors that are difficult to correct. We also found discrepancies in the calculations, which have raised doubts about the accuracy and reliability of the reported results. Therefore, we believe it is necessary to retract this article in order to maintain the integrity of scientific research and uphold the trust of our readers and the medical community. All co-authors have agreed to the retraction. We sincerely apologize for any inconvenience or confusion this may have caused.

 

According to the academic media Research Gate, Liu Zhao later responded to media inquiries via email, stating that the article was voluntarily retracted by the research team. He provided the following explanation in response:

 

As we explained to the editors of the Journal of the American Medical Association, following the publication of this paper, we plan to conduct a secondary analysis. In this process, we discovered that 109 participants who should have been in the NRT group were incorrectly placed in the EC group, and another 109 participants who should have been in the EC group were incorrectly placed in the NRT group. We immediately conducted an analysis and found that the main results had changed, therefore, we promptly wrote a letter to the editor explaining this issue and requesting the retraction of the paper.

 

Furthermore, according to publicly available information, no other articles have been affected by these issues. According to Clarivate's Web of Science, the research findings in question have been cited once.

 

Dr. Liu Chaobo, the first author of the paper by the group called 2FIRSTS, was contacted for details regarding the withdrawal notice. Dr. Liu stated that the withdrawal notice was clearly explained and no further information could be disclosed. Additionally, a call was made to the Tobacco Control and Cessation Center at the China-Japan Friendship Hospital to inquire about the details, but the staff member who answered the call claimed to be unaware of the situation.

 

2FIRSTS will continue to follow the latest developments on the research paper and its retraction.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

New Zealand Government: Repeals Vaping Device Removability Rule, Disposable Vape Ban Remains in Effect
New Zealand Government: Repeals Vaping Device Removability Rule, Disposable Vape Ban Remains in Effect
New Zealand’s coalition government will revoke the requirement for all vaping devices, including heated tobacco products, to have removable batteries starting September 1, following a legal challenge by Mason Corporation, parent company of vape retailer Shosha. The decision does not affect the ban on disposable vaping devices, which came into effect on June 17.
Jul.24 by 2FIRSTS.ai
Four Shops in Salford, UK Seized for Storing Illegal Tobacco Products Worth Over $15,000
Four Shops in Salford, UK Seized for Storing Illegal Tobacco Products Worth Over $15,000
Four shops in Salford, UK, were found with illegal cigarettes and e-cigarettes worth over £11,500 (around $15,267). The operation, known as CeCe, targets illegal sales, and the local government is urging the public to report such activities.
Aug.05 by 2FIRSTS.ai
Philip Morris Japan and Shibuya Mirai Design Launch “Action for 0” to Improve Shibuya’s Smoking Environment
Philip Morris Japan and Shibuya Mirai Design Launch “Action for 0” to Improve Shibuya’s Smoking Environment
Philip Morris Japan (PMJ) and Shibuya Mirai Design have jointly launched the “Action for 0” project as part of the “Shibuya Good Manners Project,” aiming to improve Shibuya’s smoking environment through public-private collaboration and address issues such as littering cigarette butts and passive smoking.
Aug.15 by 2FIRSTS.ai
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian police have busted a criminal syndicate distributing the new-type drug MDMA and seized e-cigarette vape oil and related items worth approximately RM1.48 million (about USD 352,000). Nine suspects were arrested, including a Thai woman. The case is being investigated under Section 39B of the Dangerous Drugs Act.
Aug.29 by 2FIRSTS.ai
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
From 2024 to 2025, Newport Trading Standards seized £6.5 million worth of illegal tobacco, e-cigarettes, and counterfeit goods in 41 raids, including 300,000 cigarettes and 12,400 e-cigarette items. The crackdown led to a year-on-year drop in tobacco sales to minors.
Jul.21 by 2FIRSTS.ai
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore’s Ministry of Health plans to classify nitazenes, a sedative found in one-third of tested e-cigarettes, as a Class C controlled substance under the Misuse of Drugs Act. The move follows reports of related fatalities. Once enforced, offenders could face mandatory rehabilitation and imprisonment, similar to penalties for hard drugs.
Jul.21 by 2FIRSTS.ai